Last reviewed · How we verify

NCT04473612

Physical Status and Upper Airway Function in Neuromuscular Patients

Completed Last updated 14 October 2020
What this trial tests

trial in Neuromuscular Diseases in 41 participants. Completed in 1 September 2020.

Timeline
20 July 2020
Primary endpoint
15 August 2020
1 September 2020

Quick facts

Lead sponsorUniversidad de Granada
StatusCompleted
Study typeOBSERVATIONAL
Enrollment41
Start date20 July 2020
Primary completion15 August 2020
Estimated completion1 September 2020
Sites1 location across Spain

Conditions studied

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 6 to 65, any sex, with Neuromuscular Diseases or Physical Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inside of studies that report an upper airway function impaired, the upper limb strength has been demonstrated to be determinant in breath, speech and swallow performance. Nevertheless, no previous studies in neuromuscular disease have explored the relation between general disability and upper airway function. There is a suspicion of upper airway which is associated with physical deterioration, however the extent to which if feeds back has not been explored.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neuromuscular Diseases

Currently open trials in the same condition.

Other Universidad de Granada trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04473612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing